EPZM Trading Below Director's Recent Buy Price

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 11, Epizyme Inc.'s Director, Carl Goldfischer, invested $60,350.00 into 5,000 shares of EPZM, for a cost per share of $12.07..